This article is cited by
-
Unveiling treatment horizons and contemporary perspectives in Peyronie’s disease – take home messages from Laurance A. Levine special issue
International Journal of Impotence Research (2024)
-
Commentary on “Phosphodiesterase type 5 inhibitors do not prevent curvature progression but shorten pain duration in the active phase of Peyronie’s disease: a retrospective cohort study”
International Journal of Impotence Research (2023)